{"id":36915,"date":"2022-06-04T22:21:47","date_gmt":"2022-06-04T22:21:47","guid":{"rendered":"https:\/\/harchi90.com\/abbott-nutrition-restarts-baby-formula-production-in-reopened-michigan-plant\/"},"modified":"2022-06-04T22:21:47","modified_gmt":"2022-06-04T22:21:47","slug":"abbott-nutrition-restarts-baby-formula-production-in-reopened-michigan-plant","status":"publish","type":"post","link":"https:\/\/harchi90.com\/abbott-nutrition-restarts-baby-formula-production-in-reopened-michigan-plant\/","title":{"rendered":"Abbott Nutrition restarts baby formula production in reopened Michigan plant"},"content":{"rendered":"
Shelves normally meant for baby formula sit nearly empty at a store in downtown Washington, DC, on May 22, 2022.<\/p>\n
Samuel Corum | AFP | Getty Images<\/p>\n<\/div>\n<\/div>\n<\/div>\n
Abbott Nutrition on Saturday resumed baby formula production at its Sturgis, Michigan, plant, a move toward addressing a nationwide shortage.<\/p>\n
The company has been given the green light from the US Food and Drug Administration after meeting “initial requirements” as part of a May 16 consent decree.<\/p>\n
The company said it will restart the production of EleCare, a formula for children who struggle to digest other products, along with other specialty and metabolic formulas.<\/p>\n
Abbott aims for an initial EleCare product release around June 20 and is working to meet guidelines to resume production of Similac and other formulas.<\/p>\n
“We understand the urgent need for formula and our top priority is getting high-quality, safe formula into the hands of families across America,” a spokesperson for Abbott said in a statement. “We will ramp production as quickly as we can while meeting all requirements.”<\/p>\n
While supply problems started early in the Covid-19 pandemic, issues worsened in part due to the February closure of the Michigan plant amid scrutiny over contamination.<\/p>\n
FDA investigations began after four infants were hospitalized with bacterial infections from drinking its powdered formula. Two of the babies died. <\/p>\n
“The FDA is continuing to work diligently to ensure the safe resumption of production of infant formula at Abbott Nutrition’s Sturgis, Michigan, facility,” the FDA said in a statement.<\/p>\n
“The agency expects that the measures and steps it is taking, and the potential for Abbott Nutrition’s Sturgis, Michigan, facility, to safely resume production in the near-term, will mean more and more infant formula is either on the way to or already on store shelves moving forward, “the FDA said. <\/p>\n
Abbott Nutrition is the largest baby formula manufacturer in the US<\/p>\n<\/div>\n<\/div>\n
.<\/p>\n","protected":false},"excerpt":{"rendered":"
Shelves normally meant for baby formula sit nearly empty at a store in downtown Washington, DC, on May 22, 2022. Samuel Corum | AFP | Getty Images Abbott Nutrition on Saturday resumed baby formula production at its Sturgis, Michigan, plant, a move toward addressing a nationwide shortage. The company has been given the green light …<\/p>\n